Correlation between peripheral blood cell transcriptomic profile and clinical parameters of chronic mitral valve disease in Dachshunds.

Studies identifying specific pathologically expressed genes have been performed on diseased myocardial tissue samples, however less invasive studies on gene expression of peripheral blood mononucleated cells give promising results. This study assessed transcriptomic data that may be used to evaluate Dachshunds with chronic mitral valve disease. Dachshunds with different stages of heart disease were compared to a control, healthy group. Microarray data analysis revealed clusters of patients with similar expression profiles. The clusters were compared to the clinical classification scheme. Unsupervised classification of the studied groups showed three clusters. Clinical and laboratory parameters of patients from the cluster 1 were in accordance with those found in patients without heart disease. Data obtained from patients from the cluster 3 were typical of advanced heart failure patients. Comparison of the cluster 1 and 3 groups revealed 1133 differentially expressed probes, 7 significantly regulated process pathways and 2 significantly regulated Ariadne Metabolic Pathways. This study may serve as a guideline for directing future research on gene expression in chronic mitral valve disease.

[1]  K. Song,et al.  Severity of Mitral Valve Degeneration Is Associated with Chromosome 15 Loci in Whippet Dogs , 2015, PloS one.

[2]  Raphael Gottardo,et al.  Orchestrating high-throughput genomic analysis with Bioconductor , 2015, Nature Methods.

[3]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[4]  M. Parzeniecka-Jaworska,et al.  The transcriptomic profile of peripheral blood nuclear cells in dogs with heart failure , 2014, BMC Genomics.

[5]  M. Sleeper,et al.  Acquired Valvular Disease , 2013 .

[6]  M. Parzeniecka-Jaworska,et al.  A retrospective study of clinical signs and epidemiology of chronic valve disease in a group of 207 Dachshunds in Poland , 2013, Acta Veterinaria Scandinavica.

[7]  真田 昌.  骨髄異形成症候群のgenome-wide analysis , 2013 .

[8]  R. Pong-Wong,et al.  Genome-wide analysis of mitral valve disease in Cavalier King Charles Spaniels. , 2012, Veterinary journal.

[9]  S. Cirera,et al.  Identification of 2 loci associated with development of myxomatous mitral valve disease in Cavalier King Charles Spaniels. , 2011, The Journal of heredity.

[10]  J. Woolliams,et al.  Heritability of premature mitral valve disease in Cavalier King Charles spaniels. , 2011, Veterinary journal.

[11]  T. Nakanishi,et al.  Effects of transforming growth factor-β3 and matrix metalloproteinase-3 on the pathogenesis of chronic mitral valvular disease in dogs. , 2011, American journal of veterinary research.

[12]  C. Hyun,et al.  The cardiac biomarker sodium-calcium exchanger (NCX-1) can differentiate between heart failure and renal failure: a comparative study of NCX-1 expression in dogs with chronic mitral valvular insufficiency and azotemia. , 2010, Journal of veterinary internal medicine.

[13]  H. Schoon,et al.  Histomorphological findings and expression of matrix metalloproteinases and their tissue specific inhibitors (TIMPs) in normal tricuspid valves and in chronic tricuspid valvular disease in dogs. , 2010, Veterinary journal.

[14]  R. Hamlin,et al.  Guidelines for the diagnosis and treatment of canine chronic valvular heart disease. , 2009, Journal of veterinary internal medicine.

[15]  S. Pak,et al.  Calcium reuptake related genes as a cardiac biomarker in dogs with chronic mitral valvular insufficiency. , 2009, Journal of veterinary internal medicine.

[16]  T. Denney,et al.  Profibrotic Growth Factor Genes in Chronic Isolated Mitral Regurgitation in the Dog Microarray Identifies Extensive Downregulation of Noncollagen Extracellular Matrix and , 2009 .

[17]  C. Hyun,et al.  The cardiac sodium-calcium exchanger gene (NCX-1) is a potential canine cardiac biomarker of chronic mitral valvular insufficiency. , 2008, Journal of veterinary internal medicine.

[18]  E. Ehrhart,et al.  Interstitial cells from dogs with naturally occurring myxomatous mitral valve disease undergo phenotype transformation. , 2008, The Journal of heart valve disease.

[19]  C. Liew,et al.  The peripheral-blood transcriptome: new insights into disease and risk assessment. , 2007, Trends in molecular medicine.

[20]  S. Chittur,et al.  Genomic expression patterns of cardiac tissues from dogs with dilated cardiomyopathy. , 2005, American journal of veterinary research.

[21]  H. Sabbah,et al.  Reduced sarcoplasmic reticulum Ca2+ uptake and increased Na+–Ca2+ exchanger expression in left ventricle myocardium of dogs with progression of heart failure , 2005, Heart and Vessels.

[22]  L. Freeman,et al.  Lymphocyte subpopulations and hematologic variables in dogs with congestive heart failure. , 2004, Journal of veterinary internal medicine.

[23]  Gordon K Smyth,et al.  Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2004, Statistical applications in genetics and molecular biology.

[24]  M. Fredholm,et al.  Epidemiology and inheritance of mitral valve prolapse in Dachshunds. , 1999, Journal of veterinary internal medicine.

[25]  L. Tilley.  Manual of Canine and Feline Cardiology , 1995 .

[26]  T. Motyl,et al.  White blood cell transcriptome correlates with renal function in acute heart failure. , 2012, International heart journal.

[27]  P. Watson.  Comparing two low-protein diets in the treatment of dogs with congenital portosystemic shunts. , 2010, Journal of veterinary internal medicine.

[28]  J. Abbott.  6 – Acquired Valvular Disease , 2007 .

[29]  G. Breithardt,et al.  Real-time RT-PCR for gene expression profiling in blood of heart failure patients-a pilot study: gene expression in blood of heart failure patients. , 2004, Basic research in cardiology.